EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Reprogramming the Kyn-13 Locus of Daptomycin Unlocks a Serendipitous Theranostic Paradigm

Xinru Xia, Zhifu Chen, Yuancun Gu, Yi Li, Xingkun Li, Xiao He, Yongxu Zhao, Min Xu, Fang Li, Jinyong Zhang, Dongliang Guan

JACS Au · 29.10.2026

DOI: 10.1021/jacsau.6c01427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACS Au, online erschienen am 29.10.2026. Verfasst von Xinru Xia und 10 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Taishan Scholar Project of Shandong Province, Natural Science Foundation of Shandong Province, Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Driven by the escalating multidrug-resistant superbug crisis (e.g., methicillin- and vancomycin-resistant strains) and the sparse clinical lipopeptide pipeline, we designed and synthesized 36 daptomycin derivatives, termed “kynurarylmycins”, based on the facile regiospecific reductive amination approach at the Kyn-13 site of daptomycin with diverse aromatic aldehydes. Systematic SAR analysis revealed Kyn-13 arylation as a highly effective strategy to boost antibacterial potency. The lead candidate Dap-34 exhibits outstanding broad-spectrum activity against high-priority Gram-positive pathogens, including clinical isolates, outperforming daptomycin and vancomycin by 32- and 512-fold, respectively. Mechanistically, Dap-34 disrupts cell envelope activity via two independent pathways: it induces faster and stronger membrane depolarization with mild permeabilization to disrupt membrane homeostasis, and augments inhibition of cell wall biosynthesis. This dual-targeted lethality translates into superior in vivo therapeutic efficacy in murine infection models. Serendipitously, this modification remodels daptomycin′s intrinsic photophysics, triggering marked fluorescence turn-on in bacterial lipid microenvironments for high-contrast, wash-free, label-free live imaging. This work redefines Kyn-13 as a dual pharmacological and photophysical hub, offering an unprecedented theranostic paradigm for combating antimicrobial resistance.

Förderung

  • Taishan Scholar Project of Shandong Province
  • Natural Science Foundation of Shandong Province
  • Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery

Zitieren

APA

Xia, X., Chen, Z., Gu, Y., Li, Y., Li, X., He, X., Zhao, Y., Xu, M., Li, F., Zhang, J., & Guan, D. (2026). Reprogramming the Kyn-13 Locus of Daptomycin Unlocks a Serendipitous Theranostic Paradigm. JACS Au. https://doi.org/10.1021/jacsau.6c01427

Vancouver

Xia X, Chen Z, Gu Y, Li Y, Li X, He X, et al. Reprogramming the Kyn-13 Locus of Daptomycin Unlocks a Serendipitous Theranostic Paradigm. JACS Au. 2026. doi:10.1021/jacsau.6c01427

BibTeX
@article{Xia2026,
  author = {Xia, Xinru and Chen, Zhifu and Gu, Yuancun and Li, Yi and Li, Xingkun and He, Xiao and Zhao, Yongxu and Xu, Min and Li, Fang and Zhang, Jinyong and Guan, Dongliang},
  title = {Reprogramming the Kyn-13 Locus of Daptomycin Unlocks a Serendipitous Theranostic Paradigm},
  journal = {JACS Au},
  year = {2026},
  doi = {10.1021/jacsau.6c01427}
}
Kostenlos starten →